In summary, spindle cell tumors with a fibrosarcoma-, LPF-, myopericytoma/hemangiopericytoma-like or myxoid morphological pattern, positive for CD34 and/or S100 protein, but without a known driver oncogenic alteration, meet the suggested criteria for NTRK fusion testing. This evidence concerns the gene CD34 and spindle cell neoplasm.